Global Radiopharmaceutical Market (By Products - Diagnostics & Therapeutics; By Region – North America-The US; Europe-The UK & Germany; and Asia Pacific-Japan & China) Outlook 2024

July 2018 | 70 pages | ID: GCA1C12DE5EEN
Rockville Research

Abstracts

Technological advancement in global radiopharmaceutical industry has brought in new radiopharmaceuticals for use in molecular imaging. These are immensely beneficial in early diagnosis of various diseases. The report “Global Radiopharmaceutical Market (By Products - Diagnostics & Therapeutics; By Region – North America-The US; Europe-The UK & Germany; and Asia Pacific-Japan & China) Outlook 2024” provides information on the current scenario, detailed market outlook of the global radiopharmaceutical market with detailed analysis of market segments such as Diagnostics & Therapeutics. The market is further analyzed with detailed market outlook for global as well as regional markets such as North America, Europe and Asia Pacific. Market outlook for overall market as well as for various segments for aforementioned regions has been provided for the period 2018-24.

The report provides comprehensive coverage on major industry drivers, restraints, and their impact on market growth during the forecast period. Furthermore, the study encompasses various market specific growth opportunities in global radiopharmaceutical market. The report has been segmented as following:-

Market Segments

• Diagnostics
• Therapeutics

Geographical Coverage

• North America - The US
• Europe – The UK & Germany
• Asia Pacific – Japan & China

Companies Coverage

• Siemens Healthineers AG
• GE Healthcare
• IBA RadioPharma Solutions
• Lantheus Holdings, Inc.
• Eckert & Ziegler

Contents

1. EXECUTIVE SUMMARY

2. RESEARCH METHODOLOGY

3. RADIOPHARMACEUTICAL

3.1 Overview
  3.1.1 Market Evolution
3.2 Category
3.3 Applications
  3.3.1 Therapeutic Uses
  3.3.2 Orthopedics
  3.3.3 Oncology
  3.3.4 Radiosynoviorthesis

4. MARKET ANALYSIS

4.1 Market Sizing (Actual & Forecasted)
4.2 Market Share Analysis
  4.2.1 Market Share by Products
  4.2.2 Market Share by Radioisotope
  4.2.3 Market Share by Source
  4.2.4 Market Share by Application
  4.2.5 Market Share by Region

5. MARKET SEGMENTATION

5.1 Diagnostics
  5.1.1 Market Sizing (Actual & Forecasted)
  5.1.2 Market Share by Products
5.2 Therapeutics
  5.2.1 Market Sizing (Actual & Forecasted)
  5.2.2 Market Share by Products

6. REGIONAL ANALYSIS

6.1 North America
  6.1.1 The US
    6.1.1.1 Market Sizing (Actual & Forecasted)
    6.1.1.2 Market Share by Products
6.2 Europe
  6.2.1 Market Sizing (Actual & Forecasted)
  6.2.2 Market Share by Products
  6.2.3 The UK
    6.2.3.1 Market Sizing (Actual & Forecasted)
  6.2.4 Germany
    6.2.4.1 Market Sizing (Actual & Forecasted)
6.3 Asia Pacific
  6.3.1 Market Sizing (Actual & Forecasted)
  6.3.2 China
    6.3.2.1 Market Sizing (Actual & Forecasted)
  6.3.3 Japan
    6.3.3.1 Market Sizing (Actual & Forecasted)

7. MARKET DYNAMICS

7.1 Industry Trends & Development
  7.1.1 Adoption of New Radiopharmaceuticals for Molecular Imaging
  7.1.2 Fusion Imaging
7.2 Growth Drivers
  7.2.1 Higher Incidence of Chronic Diseases
  7.2.2 Prevalence of Cancer and Cardiac Ailments
  7.2.3 Increasing Awareness of Radiopharmaceuticals
7.3 Challenges
  7.3.1 Stringent Regulatory Norms
  7.3.2 Scarcity of Radioisotopes
  7.3.3 High Cost of Procedure

8. COMPETITIVE LANDSCAPE

8.1 Financial Analysis
8.2 Market Share by Competitors

9. COMPANY PROFILES

9.1 Siemens Healthineers AG
9.2 GE Healthcare
9.3 IBA RadioPharma Solutions
9.4 Lantheus Holdings, Inc.
9.5 Eckert & Ziegler